Prot# BB-IND 11931-02: Injection of Autologous CD34-Postive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects with Moderate or High-Risk Critical Limb Ischemia

Project: Research project

Project Details

StatusFinished
Effective start/end date12/7/07 → 12/7/10

Funding

  • Clinical Research Management, Inc. (BB-IND 11931-02 // BB-IND 11931-02)
  • Baxter Healthcare Corporation (BB-IND 11931-02 // BB-IND 11931-02)